This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Italia. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Lino Pontello: Innovator in Pharmaceutical Preparations
Introduction
Lino Pontello is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of orally-pharmaceutical preparations designed for colon selective delivery. His innovative approach addresses the need for targeted drug release in the gastrointestinal tract.
Latest Patents
Pontello holds a patent for "Orally-pharmaceutical preparations with colon selective delivery." This invention involves an orally administrable pharmaceutical preparation that contains an active ingredient intended to be released in the lower part of the gastrointestinal tract, specifically in the large intestine and colon. The preparation consists of a core containing a therapeutically active substance, which is coated with three protection layers that have different solubility profiles. The patent also describes the manufacturing process and the use of these preparations.
Career Highlights
Lino Pontello is associated with Boehringer Ingelheim Italia, where he has been able to apply his expertise in pharmaceutical innovations. His work has contributed to advancements in drug delivery systems, enhancing the efficacy of treatments for various gastrointestinal conditions.
Collaborations
Pontello has collaborated with esteemed colleagues such as Piero Iamartino and Grazia Maffione. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical sector.
Conclusion
Lino Pontello's contributions to the field of pharmaceuticals, particularly through his patented innovations, highlight his role as a key figure in advancing drug delivery systems. His work continues to impact the industry positively, paving the way for more effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile